Epidemiology and Health Services Research: Connective Tissue Diseases/Vasculitis/Inflammatory Arthritis

Session Type: ACR Abstract Submissions
Tuesday, November 8, 2011: 9:00 AM-6:00 PM
Hall F2 - Poster Hall (McCormick Place West)
Papers:
Adult Prevalence of Systemic Autoimmune Rheumatic Diseases (SARDs) in British Columbia, Canada
J. Antonio Avina-Zubieta1, Eric C. Sayre1, Sasha Bernatsky2, Allen J. Lehman1, Kamran Shojania1, John Esdaile3 and Diane Lacaille1, 1Arthritis Research Centre of Canada/University of British Columbia, Vancouver, BC, 2McGill UHC/RVH, Montreal, QC, 3University of Calgary, Calgary, AB
The Georgia Lupus Registry: Differences in Age-Specific Incidence Rates Between Black and White Females with SLE
Cristina M. Drenkard1, Gaobin Bao1, Charles G. Helmick2, C. Gordon3, Rana Bayakly4 and S. Sam Lim1, 1Emory University, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3University of Birmingham, Birmingham, United Kingdom, 4Georgia Department of Public Health, Atlanta, GA
Epidemiology of Systemic Lupus Erythematosus in a Large United States Managed Care Population
Daniel E. Furst1, Ann Clarke2, Ancilla Fernandes3, Tim Bancroft4, Warren Greth3 and Serban R. Iorga4, 1UCLA Medical School, Los Angeles, CA, 2Montreal General Hospital, Montreal, QC, 3MedImmune LLC, Gaithersburg, MD, 4Innovus, Eden Prairie, MN
Population-Based Incidence Estimates for Systemic Lupus Erythematosus in the USA, 2002-2005:  Results From the Michigan Lupus Epidemiology and Surveillance (MILES) Program
Emily C. Somers1, Wendy Marder1, Patricia C. Cagnoli1, Emily E. Lewis1, Peter DeGuire2, Caroline Gordon3, Charles G. Helmick4, Lu Wang1, Jeffrey J. Wing1, J. Patricia Dhar5, James C. Leisen6, W. Joseph McCune1 and MILES Group7, 1University of Michigan, Ann Arbor, MI, 2MI Dept of Community Health, Lansing, MI, 3University of Birmingham, Birmingham, United Kingdom, 4Centers for Disease Control and Prevention, Atlanta, GA, 5Wayne State University, Detroit, MI, 6Henry Ford Hospital, Detroit, MI, 7Ann Arbor, MI
Impact of Autoimmune Diseases on Health Status and Health Care Utilization
Pamela Shea Poynter, Kyoung-Suk Lee, Heather Bush and Leslie J. Crofford, University of Kentucky, Lexington, KY
Racial Disparities In Treatment Preferences Among Lupus Patients In An Urban Academic Center
Ernest R. Vina, Christopher M. Masi, Stephanie L. Green and Tammy O. Utset, University of Chicago, Chicago, IL
Effort-Reward Imbalance in Patients with Systemic Lupus Erythematodes?
Jutta G. Richter, Thomas Muth, Birthe Koerbl, Nicole Hoffmann, Tobias Koch, Johannes Siegrist and Matthias Schneider, Heinrich-Heine-University, Duesseldorf, Germany
Missed Work Days In Systemic Lupus Erythematosus
Jie Xu, Hong Fang and Michelle Petri, Johns Hopkins University School of Medicine, Baltimore, MD
Life and Job Satisfaction in Patients with Systemic Lupus Erythematosus
Jutta G. Richter, Thomas Muth, Birthe Koerbl, Mia Vidakovic, Tobias Koch and Matthias Schneider, Heinrich-Heine-University, Duesseldorf, Germany
Impact of Systemic Lupus Erythematosus on Employment and Work Productivity in the US
Ellen Sulcs1, Mechele Lee2, Cindy P. Garris3 and Priti M. Jhingran3, 1Harris Interactive Inc., New York, NY, 2Harris Interactive Inc., New York, 3GlaxoSmithKline R&D, Research Triangle Park, NC
Association of Body Mass Index, Race/Ethnicity and Gender in a Cohort of Systemic Lupus Erythematosus Patients with Diabetes and/or Hypertension
Jonea Lim, Harold Hamm Oklahoma Diabetes Center, University of Oklahoma Health Science Center, Oklahoma City, OK, Nasir Mushtaq, University of Oklahoma Health Science Center College of Public Health, Oklahoma City, OK, Rachna Aggarwal, University of Oklahoma Health Science Center; Oklahoma Medical Research Foundation, OK and R. Hal Scofield, Oklahoma Medical Research Foundation, Oklahoma City, OK
Everyday Stress, C-Reactive Protein, and Systemic Lupus Erythematosus
Amanda Eudy1, Anissa I. Vines1, Charles Poole1, Carolina Lupus Study Investigators2 and Christine G. Parks3, 1University of North Carolina, Chapel Hill, NC, 2USA, 3NIH/NIEHS, Research Triangle Park, NC
Stressful Life Experiences and Inflammation in the Carolina Lupus Study: An Open-Ended Query on Stress
Christine G. Parks, NIH/NIEHS, Research Triangle Park, NC, Anissa I. Vines, University of North Carolina, Chapel Hill, NC, Amanda Eudy, UNC Chapel Hill, Chapel Hill, NC and Carolina Lupus Study Investigators, USA
LupusPRO: Cross Cultural Validation Study for Lupus in the Philippines
S. Navarra1, Rachel A. Mikolaitis2, Joel A. Block2 and Meenakshi Jolly2, 1University of Santo Tomas Hospital, Manila, Philippines, 2Rush University Medical Center, Chicago, IL
Spanish LupusPRO: Cross Cultural Validation Study for Lupus
Meenakshi Jolly1, Joel A. Block1, Rachel A. Mikolaitis1, Daniel Wallace2, Sergio Duran-Barragán3, Ana M. Bertoli4, Sergio Toloza5, Ivana Blazevic6, Luis M. Vila7, Dilrukshie Cooray8, Emmanuel P. Katsaros9, Karina Marianne D. Torralba10, Michael H. Weisman11 and Graciela S. Alarcon12, 1Rush University Medical Center, Chicago, IL, 2Cedars-Sinai/UCLA, Los Angeles, CA, 3UIECD, Guadalajara, Mexico, Guadalajara, Mexico, 4Instituto Reumatológico Strusberg, Cordoba, Cordoba, Argentina, 5Hospital San Juan Bautista, Catamarca, Argentina, 6University of Buenos Aires, Buenos Aries, Argentina, 7University of PuertoRico Medical Sciences Campus, San Juan, PR, 8Harbor UCLA Medical Center, Torrance, CA, 9Loma Linda Univ, Loma Linda, CA, 10USC Keck Schl of Medicine, Los Angeles, CA, 11Cedars-Sinai Medical Center, Los Angeles, CA, 12University of Alabama at Birmingham, Birmingham, AL
Epidemiology of Systemic Sclerosis in a Large United States Managed Care Population
Daniel E. Furst1, Ancilla Fernandes2, Serban R. Iorga3, Warren Greth2 and Tim Bancroft3, 1UCLA Medical School, Los Angeles, CA, 2MedImmune LLC, Gaithersburg, MD, 3Innovus, Eden Prairie, MN
Population-Based Prevalence Estimates of Myositis in First Nations Relative to Non-First Nations Canadians
Cheryl CM Barnabe1, Lawrence Joseph2, Patrick Belisle2, Jeremy Labrecque3, Lawrence W. Svenson1, Steven M. Edworthy1, Susan G. Barr1, Marvin J. Fritzler1, Christine A. Peschken4, Brenda Hemmelgarn1 and Sasha Bernatsky3, 1University of Calgary, Calgary, AB, 2McGill University Health Centre, Montreal, QC, 3McGill UHC/RVH, Montreal, QC, 4University of Manitoba, Winnipeg, MB
Development and Content Validity of the Hand Disability in Systemic Sclerosis—Digital Ulcers (HDISS-DU) Scale
Dinesh Khanna1, Serge Poiraudeau2, Heather Gelhorn3, Elke Hunsche4, Kelly Papadakis4, Loic Perchenet4, Maria Stoeckl Mattera5, Margaret Vernon5 and Luc Mouthon2, 1University of Michigan, Ann Arbor, MI, 2Hopital Cochin, Paris, France, 3United BioSource Corporation, Golden, CO, 4Actelion Pharmaceuticals Ltd, Allschwil, Switzerland, 5United BioSource Corporation, Bethseda, Bethesda, US., MD
Epidemiology of Idiopathic Inflammatory Myopathy in a Large United States Managed Care Population
Daniel E. Furst1, Anthony A. Amato2, Serban R. Iorga3, Kavita Gajria4 and Ancilla Fernandes4, 1UCLA Medical School, Los Angeles, CA, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Innovus, Eden Prairie, MN, 4MedImmune LLC, Gaithersburg, MD
Descriptive Epidemiology of Granulomatosis with Polyangitis (Wegener’s), Microscopic Polyangitis, Polyarteritis Nodosa and Goodpasture’s Syndrome in the United States
Martin M. Crane, GlaxoSmithKline, Research Triangle, NC, Vincent X. Rabatin, GlaxoSmithKline, Research Triangle Park, NC and Alfred Mahr, Hospital Saint-Louis, Paris, France
Prevalence of ANCA Associated Vasculitis and Polyarteritis Nodosa in Southern Sweden-Revisited 2010
Aladdin Mohammad, Skåne University Hospital, Lund, Sweden and Mårten Segelmark, Linköping University, Linköping, Sweden
Informed Consent for Treatment of ANCA-Associated Vasculitis
Raluca Cozmuta, St. Vincent Medical Center, Bridgeport, CT, Peter A. Merkel, Boston University School of Medicine, Boston, MA and Liana Fraenkel, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare Systems, New Haven, CT
Increased Prevalence of Metabolic Syndrome and Higher Serum Leptin Levels in Patients with Psoriatic Arthritis
Devy Zisman1, S. Nissan1, Lihi Eder1, J. Feld1, M.A Rahat1, Muna Elias1, D. Rimar1, A. Laor1 and H. Bitterman2, 1Carmel Medical Center, Haifa, Israel, 2Carmel Medical Center , The Ruth and Bruce Rappaport Faculty of Medicine Technion, Haifa, Israel
Quantifying the Harmful Effects of Psoriatic Diseases on Quality of Life Outcomes - COMPASS III Study
Deepan Dalal1, Yih Chang Lin1, Danielle Brennan1, Katherine Wolski1, Neil Borkar2, Neil J. Korman2, Diane Dylinski1 and M. Elaine Husni1, 1Cleveland Clinic Foundation, Cleveland, OH, 2University Hospitals - Case Medical Center, Cleveland, OH
Trends In Lipid Profiles In Patients with Psoriasis: A Population-Based Analysis
Bharath Manu Akkara Veetil, Eric L. Matteson, Hilal Maradit-Kremers, Marian T. McEvoy and Cynthia S. Crowson, Mayo Clinic, Rochester, MN
Cardiovascular Risk In Psoriasis: A Population Based Analysis with Assessment of the Framingham Risk Score
Bharath Manu Akkara Veetil, Eric L. Matteson, Hilal Maradit-Kremers, Marian T. McEvoy and Cynthia S. Crowson, Mayo Clinic, Rochester, MN
Learned Helplessness Predicts 2-Year Change in Functional Disability in Patients with Inflammatory Polyarthritis
Elizabeth M. Camacho1, Suzanne Verstappen1, Diane K. Bunn2 and Deborah DPM Symmons1, 1University of Manchester, Manchester, United Kingdom, 2University of East Anglia, Norwich, United Kingdom
Adverse Pregnancy Outcomes Before Symptom Onset Are Associated with a Worse Disease Outcome in Women with Recent-Onset Inflammatory Polyarthritis
Elizabeth M. Camacho1, Suzanne Verstappen1, Mark Lunt1, Diane K. Bunn2 and Deborah P.M. Symmons3, 1University of Manchester, Manchester, United Kingdom, 2University of East Anglia, Norwich, United Kingdom, 3The University of Manchester, Manchester, United Kingdom
Pregnancy Outcomes In Women Exposed to Adalimumab: An Update On the Autoimmune Diseases In Pregnancy Project
Diana Johnson, Yunjun Luo, Kenneth Lyons Jones and Christina Chambers, University of California, San Diego, La Jolla, CA
Maternal Smoking and the Risk of Juvenile Idiopathic Arthritis
Susan Shenoi1, Carol A. Wallace1 and Beth A. Mueller2, 1Seattle Children's Hospital, University of Washington, Seattle, WA, 2University of Washington,, Seattle, WA
Prevalence of Depression and Concomitant Risk Factors in Children with Rheumatic Disease
Stacey E. Tarvin1, Nicole M. Taylor2, Christine M. Raches2, Lisa M. Macharoni2, Joseph E. Hansel2 and Susan H. Ballinger1, 1Riley Hospital for Children, Indianapolis, IN, 2University of Indianapolis, Indianapolis, IN
Disease Modifying Anti-Rheumatic Drugs Compliance Study
Kateryna Vostretsova1, Pam Rogers1, Darby JS Thompson2 and Diane Lacaille3, 1Arthritis Research Centre, Vancouver, BC, 2Simon Fraser University, Vancouver, BC, 3Arthritis Research Centre; University of British Columbia, Vancouver, BC
Improving the Assessment of Minimal Important Change by Combining Health State Transition Questions with Patient Acceptable Symptom State and Patient Willingness to Alter Therapy
Jos Hendrikx, Jaap Fransen, Wietske Kievit and Piet LC van Riel, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
The Accuracy of Identifying Kidney Disease in Administrative Databases for Rheumatic Disease Research - A Systematic Review of Validation Studies
Bindee Kuriya, University of Toronto, Toronto, ON, Ziv Harel, Division of Nehprology, University of Toronto, Toronto and Diane Lacaille, Arthritis Research Ctr Canada, Vancouver, BC
A Systematic Review of Validation Studies of Administrative Data Used to Identify Infections
Claire Barber, Mount Sinai Hospital, Toronto, ON, Diane V. Lacaille, Arthritis Research Ctr Canada, Vancouver, BC, Joan E. Wither, Toronto Western Research Institute, University Health Network, Toronto, ON and Paul R. Fortin, Toronto Western Hospital and University of Toronto, Toronto, ON
Consensus Statements Concerning the Use of Administrative Data in Rheumatology Research and Surveillance
Diane Lacaille, Arthritis Research Ctr; University of British Columbia, Vancouver, BC, Lisa Lix, University of Saskatchewan, Saskatoon, SK, Sasha Bernatsky, McGill UHC/RVH, Montreal, QC, Siobhan O'Donnell, Public Health Agency of Canada, Ottawa, ON, Claire Bombardier, Institute for Work & Health, Toronto, ON and Administrative Data Rheumatology Research & Surveillance
An Evaluation of the Extended Item Euroqol Compared with the Standard Euroqol
Kaleb Michaud, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE and Frederick Wolfe, National Data Bank for Rheumatic Diseases, Wichita, KS
Increased Ability to Meet Occupational, Home or Leisure Requirements in Patients Starting Biologic Agents
Anja Strangfeld1, Diana Pantigoso1, Peter Herzer2, Hans Peter Tony3, Elke Wilden4, Joachim Listing1 and Angela Zink5, 1Deutsches Rheumaforschungszentrum, Berlin, Germany, 2University of Munich, Munich, Germany, 3Rheumatology, University of Würzburg, Würzburg, Germany, 4Rheumatologist, Köln, Germany, 5Deutsches Rheumaforschungszentrum and Charité University Medicine, Berlin, Germany
Distribution of Tumor Necrosis Factor Inhibitor Use Across Indications in Sweden: Nationwide Register-Linkage Study
Martin Neovius1, Jonas Eriksson1, Julia F. Simard1, Johan Askling1 and ARTIS Study Group2, 1Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Stockholm, Sweden
Cross-Sectional Validation of the Patient Reported Outcome Measurement Information System Pediatric Scales in Juvenile Idiopathic Arthritis, Childhood Systemic Lupus Erythematosus, and Juvenile Dermatomyositis
Esi Morgan DeWitt1, Heather Gross2, Brian D. Stucky3, Yang Liu3, David Thissen3, Daniel J. Lovell1, Carol A. Wallace4, James F. Fries5, Bonnie Bruce6, Egla C. Rabinovich7, Laura E. Schanberg7 and Darren Dewalt2, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3University of North Carolina at Chapel Hill, Chapel Hill, 4Childrens Hosp & Regional Med, Seattle, WA, 5Stanford Univ Medical Center, Palo Alto, CA, 6Stanford Dept of Medicine, Palo Alto, CA, 7Duke University Medical Center, Durham, NC
Assesment of Disease Activity in Ankylosing Spondylitis: Comparison of Rapid3, Basdai, Basfi, and Asdas Scores in Routine Care
Muhammet Cinar1, Sedat Yilmaz1, Suleyman Serdar Koca2, Hakan Erdem1, Salih Pay1, Yusuf Yazici3 and Ismail Simsek1, 1Division of Rheumatology, Gulhane School of Medicine, Ankara, Turkey, 2Department of Rheumatology, Faculty of Medicine, Firat University, Elazig, Turkey, 3Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY
Prevention of Latent Tuberculosis and Toxicity of Isoniazid in Patients Treated by Anti-Tumor Necrosis Factor Alpha in the Czech National Register 
Katarina Hviscova1, Liliana Sedova1 and Karel Pavelka2, 1Charles University, Prague, Czech Republic, 21Institute of Rheumatology, Department of Experimental Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
Internet-Based Patient Registry and Biospecimen Collection: One Year Experience of the Arthritis Internet Registry
Kaleb Michaud1, Kimberly Harp1, Rebecca Schumacher1, Stanley J. Naides2, William F. Patten2, Beth Axtell3 and Robert M. Plenge4, 1National Data Bank for Rheumatic Diseases, Wichita, KS, 2Quest Diagnostics Nichols Inst, San Juan Capistrano, CA, 3Arthritis Foundation, Atlanta, GA, 4Brigham and Women's Hospital, Boston, MA
Improving Clinical Trial Recruitment in a Real World Practice. Results From the Canadian Early Arthritis Cohort
Pooneh S.Akhavan, University of Toronto, Toronto, ON, Vivian Bykerk, Brigham & Women's Hospital, Boston, MA, Ye Sun, Mount Sinai Hospital, Toronto, ON, Boulos Haraoui, Institut de Rhumatologie, Montreal, QC, J. Carter Thorne, Southlake Regional Health Centre, Newmarket, Newmarket, ON, Janet E. Pope, St. Joseph's Health Care, University of Western Ontario, London, ON, Carol A. Hitchon, University of Manitoba, Winnipeg, MB, Diane S. Ferland, LaSalle, QC, Gilles Boire, CHUS - Sherbrooke University, Sherbrooke, QC, Edward C. Keystone, Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, ON and CATCH Investigators, Toronto, ON
Reproducibility of Composite Scores: Disease Activity 28-Joints Score, Simplified Disease Activity Score and Clinical Disease Activity Score In the Evaluation of Rheumatoid Arthritis(Ra) Disease Activity: Pursuit for A Gold Standard
Lissiane K. N. Guedes1, Ana C. M. Ribeiro2, Julio C. B. Moraes2, Carla G.S. Saad3, Nadia E. Aikawa3, Eduardo F. Borba Neto4, Sandra Pasotto2, Jozelio F. Carvalho3, Eloisa Bonfa2 and Ieda Laurindo5, 1University of Sao Paulo, Sao Paulo, Brazil, 2Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 3Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil, 5Universidade de São Paulo, Sao Paulo, Brazil
Doctor-Patient Involvement in Biologic Treatment Choice:the Benefits of a Collaborative Approach
Chris Martin and Katrina Johnson, The Research Partnership, London, United Kingdom
Older Age, Male Gender, Current Smoking and Worse Disease Activity Are Predictors of Respiratory Disease Mortality in Patients with Inflammatory Polyarthritis: Results From the Norfolk Arthritis Register
Suzanne MM Verstappen1, Mark Lunt1, Diane K. Bunn2, Tarnya Marshall3 and Deborah PM Symmons1, 1Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 2Norfolk Arthritis Register, School of Medicine Health Policy and Practice Faculty of Health UEA, Norwich, United Kingdom, 3Norfolk and Norwich University Hospitals Trust, Norwich, UK, Norwich, United Kingdom, Norwich, United Kingdom
The Association Between Clinical and Lifestyle Factors and the Development of Inflammatory Polyarthritis and Rheumatoid Arthritis. Results From the European Prospective Investigation of Cancer (Norfolk) Study and the Norfolk Arthritis Register
Manjari Lahiri1, Catharine Morgan1, Robert N. Luben2, Diane K. Bunn3, Mark Lunt1, Nick Warehan2, Suzanne M.M. Verstappen1, Deborah P. M. Symmons1, Kay-Tee Khaw2 and Ian N. Bruce4, 1Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 2University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 3University of East Anglia, Norwich, United Kingdom, 4A, Manchester, United Kingdom
Low Levels of Formal Education Generally Are As Significant As High Age and Long Duration of Disease to Identify Poor Clinical Status in Patients with Most Rheumatic Diseases
Isabel Castrejón1, Yusuf Yazici2 and Theodore Pincus1, 1NYU Hospital for Joint Diseases, New York, NY, 2Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY
Higher Fruit and Fructose Consumption Is Associated with a Reduced Risk of Inflammatory Polyarthritis and Rheumatoid Arthritis in Men. Results From the European Prospective Investigation of Cancer (Norfolk) and the Norfolk Arthritis Register
Manjari Lahiri1, Catharine Morgan1, Robert N. Luben2, Marleen Lentjes3, Diane K. Bunn4, Mark Lunt1, Nick Wareham2, Suzanne M.M. Verstappen1, Deborah P. M. Symmons1, Kay-Tee Khaw2 and Ian N. Bruce5, 1Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 2University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 3Cambridge, United Kingdom, 4University of East Anglia, Norwich, United Kingdom, 5A, Manchester, United Kingdom
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.